Syncom Formulations (India) Ltd.

SYNCOMF

₹21.5

-1.6% (-0.35)

Market Cap

₹2,021 Cr.

P/E

40.88

About

Syncom Formulations (India) Ltd. is a pharmaceutical company that manufactures and markets a wide range of products in various dosage forms such as tablets, capsules, liquids, and powders. They also p… Read more

Syncom Formulations (India) Ltd. is a pharmaceutical company that manufactures and markets a w… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Promoter Holding

Promoter has not sold any shares in the last 90 days
Other Income

Other income component is making ratios of the company look optically better
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has decreased over last 10 years more due to earnings
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Capex

Drug Delivery Break-Up

Raw Material Break-Up

Asset Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Syncom Formulations (India) Ltd. Business

What does Syncom Formulations do?

Syncom Formulations (India) Ltd. specializes in manufacturing and marketing a wide range of pharmaceutical products in various dosage forms such as tablets, capsules, liquids, injectibles, and herbal products.

Who are the competitors of Syncom Formulations?

Syncom Formulations major competitors are Beta Drugs, Novartis, Bliss GVS Pharma, Jagsonpal Pharma, Indoco Remedies, Panacea Biotec, Lincoln Pharma.
Market Cap of Syncom Formulations is ₹2,021 Crs.
While the median market cap of its peers are ₹1,827 Crs.

Is Syncom Formulations financially stable compared to its competitors?

Syncom Formulations seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release				Sep
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd.

About

Timeline

Company Timeline

8 Yes

2 Neutral

7 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Pledge

Retail Holding

Depreciation Effect

Promoter Holding

Other Income

Revenue Recognition

Price & Performance

Capex vs ROCE

ROE

Working Capital

Debt

Balance Sheet Strength

Share price

Current vs Historic Valuation

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operating Profit Break-Up

UNLOCK PREMIUM

Capex

UNLOCK PREMIUM

Drug Delivery Break-Up

UNLOCK PREMIUM

Raw Material Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

What does Syncom Formulations do?

Who are the competitors of Syncom Formulations?

Is Syncom Formulations financially stable compared to its competitors?

SIGN UP FOR FREE